Search for Companies, Tipsters or Sources…
Companies
Tipsters
Brokers
Sources
Or view the latest share tips
Company Results
Tipster results
Broker results
Sources results
Fund Manager results
Tips from these results
Recent Share tips:
- Hold Eco buildings Group (ECOB) by Hot Stock Rockets in ShareProphets
- Sell Morgan Advanced Materials (MGAM) by Tom Winnifrith in ShareProphets
- Sell Morgan Advanced Materials (MGAM) by Steve Moore in ShareProphets
- Watch BAE Systems (BA.) by Royston Wild in The Motley Fool
- Buy Spirax Group (SPX) by Jefferies
- Buy Hill and Smith (HILS) by Berenberg
- Buy GB Group (GBG) by Deutsche Bank
- Outperform CMC Markets (CMCX) by RBC Capital
- Buy Entain (ENT) by Deutsche Bank
- Sector Perform HSBC Holdings (HSBA) by RBC Capital
- Buy Aviva (AV.) by Goldman Sachs
- Buy Aviva (AV.) by Berenberg
- Equal Weight Antofagasta (ANTO) by Barclays
- Watch Legal & General Group (LGEN) by Zaven Boyrazian in The Motley Fool
- Hold Safestore Holdings (SAFE) by Zaven Boyrazian in The Motley Fool
- Watch Atalaya Mining (ATYM) by Zaven Boyrazian in The Motley Fool
- Hold Antofagasta (ANTO) by Berenberg
- Buy Savills (SVS) by Berenberg
- Buy Amaroq Minerals Ltd. Npv (DI) (AMRQ) by Nigel Somerville in ShareProphets
- Sell Distil (DIS) by Steve Moore in ShareProphets
AstraZeneca (AZN) Share Price
Health Care Sector
NOTE: This is based on 1,285 open tips for AstraZeneca (AZN)
| Latest Bid : 11,560.00p | Latest Ask : 11,564.00p |
| High Today : 11,690.00p | Low Today : 11,546.00p |
| This Years High : 15,316.00p | This Years Low : 10,956.00p |
| Volume : 463,496 | MKT Cap : £179242M |
| Trading Velocity : Premium Only | Activity Score : Premium Only |
| Consensus Score : Premium Only | Momentum Score : Premium Only |
AstraZeneca (AZN) Overview
A world-leading pharmaceutical group, AstraZeneca was created in 1999 via the merger of Sweden's Astra and the UK's Zeneca, which had been demerged from chemicals group ICI in 1993. About half of its total sales are generated from the US, with over a third of revenues coming from its gastrointestinal treatments such as Prilosec (Losec) and Nexium.AstraZeneca (AZN) Latest Tips
| Type | Tipster | SectorScore | Start date | Performance |
|---|---|---|---|---|
| Sell | Deutsche Bank | Premium Only | 2026-08-05 18:00:00 05/08/2026 | 4.98% |
| Sector Perform | Deutsche Bank | Premium Only | 2026-08-04 10:30:00 04/08/2026 | 0.21% |
| Sell | Deutsche Bank | Premium Only | 2026-07-28 15:00:00 28/07/2026 | 11.93% |
| Buy | Goldman Sachs | Premium Only | 2026-07-28 09:35:00 28/07/2026 | -8.96% |
| Buy | Citi | Premium Only | 2026-07-28 09:10:00 28/07/2026 | -9.06% |
AstraZeneca (AZN) Active Short Positions
| Fund Manager | Position | Date | ||
|---|---|---|---|---|
| No active short positions | ||||
| Latest Bid : 11,560.00p | Latest Ask : 11,564.00p |
| High Today : 11,690.00p | Low Today : 11,546.00p |
| This Years High : 15,316.00p | This Years Low : 10,956.00p |
| Volume : 463,496 | MKT Cap : £179242M |
AstraZeneca Overview
A world-leading pharmaceutical group, AstraZeneca was created in 1999 via the merger of Sweden's Astra and the UK's Zeneca, which had been demerged from chemicals group ICI in 1993. About half of its total sales are generated from the US, with over a third of revenues coming from its gastrointestinal treatments such as Prilosec (Losec) and Nexium.NOTE: This description is in part generated by ChatGPT and not an endorsement by or the opinion of Stockomendation Ltd.
Latest AstraZeneca Tips
| Type | Tipster | SectorScore | Start date | Performance |
|---|---|---|---|---|
| Sell | Deutsche Bank | Premium Only | 2026-08-05 18:00:00 05/08/2026 | 4.98% |
| Sector Perform | Deutsche Bank | Premium Only | 2026-08-04 10:30:00 04/08/2026 | 0.21% |
| Sell | Deutsche Bank | Premium Only | 2026-07-28 15:00:00 28/07/2026 | 11.93% |
| Buy | Goldman Sachs | Premium Only | 2026-07-28 09:35:00 28/07/2026 | -8.96% |
| Buy | Citi | Premium Only | 2026-07-28 09:10:00 28/07/2026 | -9.06% |